High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental

Natalia Carrillo-López1, Sara Panizo1, Cristina Alonso-Montes1

  • 1Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), REDinREN-ISCIII, Oviedo, Spain.

Insights

In chronic kidney disease (CKD), high parathyroid hormone (PTH) worsens vascular calcification and bone loss. Lowering PTH in hyperphosphatemic rats reduced vascular calcium and bone loss by inhibiting osteogenic differentiation.

Area of Science:

  • Nephrology
  • Endocrinology
  • Vascular Biology

Background:

  • Chronic kidney disease (CKD) is associated with elevated serum phosphate and parathyroid hormone (PTH).
  • These elevations contribute to vascular calcification (VC) and bone loss.
  • Distinguishing the specific roles of high phosphorus (HP) and PTH in these complications is crucial.

Purpose of the Study:

  • To investigate the individual contributions of high phosphorus (HP) and elevated parathyroid hormone (PTH) to vascular calcification (VC) and bone loss in a rat model of CKD.
  • To elucidate the molecular mechanisms underlying these contributions.

Main Methods:

  • Nephrectomized rats were fed a high phosphorus (HP) diet.
  • Rats underwent either sham operation or parathyroidectomy with PTH 1-34 supplementation to normalize serum PTH levels.
  • Vascular and bone tissues were analyzed for calcification and resorption markers.
  • Vascular smooth muscle cells (VSMCs) were studied in vitro.

Main Results:

  • Parathyroidectomy with PTH 1-34 supplementation significantly reduced aortic calcium by 80% in uraemic rats, attenuating osteogenic differentiation and increasing sclerostin.
  • Bone loss was prevented by attenuating bone resorption and increasing Wnt inhibitors.
  • Serum calcitriol decreased by 70% despite reduced FGF23, challenging FGF23's role in calcitriol regulation.
  • In vitro, high PTH enhanced VSMC calcification, while low PTH attenuated it via PTH1R signaling.

Conclusions:

  • In hyperphosphatemic CKD, inadequate suppression of high PTH exacerbates HP-induced osteogenic VSMC differentiation.
  • High PTH also reduces vascular sclerostin levels, a key inhibitor of calcification.
  • These findings highlight the detrimental role of excessive PTH in CKD-related vascular and bone pathology.
Abstract

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.1K
Hormonal Regulation01:40

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
48.2K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
739
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
664
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
478
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
397